BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Drug Development

  Ablynx Announces New Compelling Results on Ozoralizumab (ATN-103) in Rheumatoid Arthritis

  June 25, 2012

   · 

  2 min read
• Pharm Country

  Multiple Myeloma, Shift in Drug Discovery Targeting Protein Homeostasis

  June 25, 2012

   · 

  1 min read
• FDA

  Shire plc Hit as US Approves New Generic ADHD Drug

  June 25, 2012

   · 

  1 min read
• Drug Development

  FDA: Amylin Pharmaceuticals, Inc. Concealed Heart Safety Risks of Key Diabetes Drug

  June 25, 2012

   · 

  1 min read
• Policy

  Pfizer Inc., Bristol-Myers Squibb Company Pill Eliquis Fails to Win FDA Approval; Clot Preventer Delayed

  June 25, 2012

   · 

  6 min read
• Biotech Bay

  MAP Pharmaceuticals, Inc. to Present Data on LEVADEX® at the 54th Annual Scientific Meeting of the American Headache Society

  June 25, 2012

   · 

  2 min read
• Deals

  Teleflex Incorporated Buys SEMPRUS BioSciences for Up to $80 Million

  June 25, 2012

   · 

  4 min read
• FDA

  ETView Medical, Ltd. Announced CE Clearance for the VivaSight™-DL line of Innovative Airway Devices

  June 25, 2012

   · 

  4 min read
• Business

  Patricia Scheller Named CEO of Viveve

  June 25, 2012

   · 

  2 min read
• Policy

  MAP Pharmaceuticals, Inc. to Resubmit Application for Migraine Treatment This Year

  June 25, 2012

   · 

  4 min read